-
-
-
-
-
-
-
Novo Nordisk reports Q1 earnings on Wednesday: Analysts flag key focus topics
-
-
-
-
-
-
-
Eli Lilly Q1 earnings preview: analysts eye outlook for obesity drugs
-
-
-
-
-
-
-
Lilly confirms date and conference call for first-quarter 2026 financial results announcement
-
-
-
-
-
-
-
This pharma stock is 'poised to outperform in 2026,' Wolfe says
-
-
-
-
-
-
-
Bernstein Weighs In on Eli Lilly (LLY) Stock Following Novo Pre-Release
-
-
-
-
-
-
-
Eli Lilly's Mounjaro added to China's state insurance list for diabetes treatment
-
-
-
-
-
-
-
Eli Lilly raises annual revenue guidance amid strong weight-loss drug demand
-
1,203,730 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

